COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management-Reference-Cited by-同舟云学术

COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management

Published:2020-07-02 Issue:9 Volume:20 Page:959-964
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Russano Marco¹,Citarella Fabrizio¹,Napolitano Andrea¹,Dell’Aquila Emanuela¹,Cortellini Alessio²³^ORCID,Pantano Francesco¹,Vincenzi Bruno¹,Tonini Giuseppe¹,Santini Daniele¹

Affiliation:

1. Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy

2. Department of Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy

3. Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy

Funder

declared

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1789097

Reference50 articles.

1. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

2. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

3. Risk of COVID-19 for patients with cancer

4. Susceptibility Analysis of COVID-19 in Smokers Based on ACE2

5. New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What did we learn about tocilizumab use against COVID-19? A single-center observational study from an intensive care unit in Serbia;Frontiers in Medicine;2023-11-14

2. Common statement of experts of the Polish Oncological Society, Polish Lung Cancer Group, Polish Society of Lung Diseases, Polish Society of Gastroenterology, Polish Society of Endocrinology, and the Polish Society of Cardiology for minimal requirements in diagnosis and monitoring of selected adverse events of immunotherapy in oncological patients;Oncology in Clinical Practice;2023-04-21

3. Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology;PLOS ONE;2023-03-29

4. Immune checkpoint inhibitor-related pneumonitis and COVID-19: a case-matched comparison of CT findings;La radiologia medica;2023-01-21

5. Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy;Cancers;2022-12-01